Human Papillomavirus (HPV) type 18 induces extended growth in primary human cervical, tonsillar, or foreskin keratinocytes more effectively than other high-risk mucosal HPVs

Journal of Virology

Volumn 83, Issue 22, 2009, Pages 11784-11794

  Lace, Michael J ^a,b   Anson, James R ^a   Klingelhutz, Aloysius J ^b   Lee, John H ^b   Bossler, Aaron D ^b   Haugen, Thomas H ^a,b   Turek, Lubomir P ^a,b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CELL CULTURE; COLONY FORMING UNIT; COMPARATIVE STUDY; CONTROLLED STUDY; GENETIC TRANSCRIPTION; GENOME; GENOMIC INSTABILITY; HIGH RISK PATIENT; HUMAN; HUMAN CELL; HUMAN PAPILLOMAVIRUS TYPE 11; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; HUMAN PAPILLOMAVIRUS TYPE 31; KERATINOCYTE; PREPUCE; PRIORITY JOURNAL; RISK FACTOR; SOUTHERN BLOTTING; TONSIL CELL; UTERINE CERVIX EPITHELIUM; VIROGENESIS; VIRUS CULTURE; VIRUS GENE; VIRUS GENOME; VIRUS REPLICATION; VIRUS STRAIN; WART VIRUS;

BLOTTING, SOUTHERN; CELLS, CULTURED; CERVIX UTERI; FEMALE; FORESKIN; HUMAN PAPILLOMAVIRUS 18; HUMANS; KERATINOCYTES; MALE; PALATINE TONSIL; PAPILLOMAVIRIDAE; TRANSCRIPTION, GENETIC; VIRUS REPLICATION;

HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; PAPILLOMAVIRIDAE;

EID: 70350289803     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.01370-09     Document Type: Article

References (72)

1. Allen-Hoffmann, B. L., S. J. Schlosser, C. A. Ivarie, C. A. Sattler, L. F. Meisner, and S. L. O'Connor. 2000. Normal growth and differentiation in a spontaneously immortalized near-diploid human keratinocyte cell line, NIKS. J. Investig. Dermatol. 114:444-455.
2. Barbosa, M. S., and R. Schlegel. 1989. The E6 and E7 genes of HPV-18 are sufficient for inducing two-stage in vitro transformation of human keratinocytes. Oncogene 4:1529-1532. (Pubitemid 20008936)
3. Berger, K. L., F. Barriga, M. J. Lace, L. P. Turek, G. J. Zamba, F. E. Domann, J. H. Lee, and A. J. Klingelhutz. 2006. Cervical keratinocytes containing stably replicating extrachromosomal HPV-16 are refractory to transformation by oncogenic H-Ras. Virology. 356:68-78.
4. Boshart, M., L. Gissmann, H. Ikenberg, A. Kleinheinz, W. Scheurlen, and H. zur Hausen. 1984. A new type of papillomavirus DNA, its presence in genital cancer biopsies and in cell lines derived from cervical cancer. EMBO J. 3:1151-1157.
5. Boukamp, P., R. T. Petrussevska, D. Breitkreutz, J. Hornung, A. Markham, and N. E. Fusenig. 1988. Normal keratinization in a spontaneously immortalized aneuploid human keratinocyte cell line. J. Cell Biol. 106:761-771. (Pubitemid 18089976)
6. Bousarghin, L., A. Touze, P. Y. Sizaret, and P. Coursaget. 2003. Human papillomavirus types 16, 31, and 58 use different endocytosis pathways to enter cells. J. Virol. 77:3846-3850. (Pubitemid 36297304)
7. Burger, R. A., B. J. Monk, T. Kurosaki, H. Anton-Culver, S. A. Vasilev, M. L. Berman, and S. P. Wilczynski. 1996. Human papillomavirus type 18: association with poor prognosis in early stage cervical cancer. J. Natl. Cancer Inst. 88:1361-1368.
8. Chakrabarti, O., K. Veeraraghavalu, V. Tergaonkar, Y. Liu, E. J. Androphy, M. A. Stanley, and S. Krishna. 2004. Human papillomavirus type 16 E6 amino acid 83 variants enhance E6-mediated mitogen-activated protein kinase signaling and differentially regulate tumorigenesis by notch signaling and oncogenic Ras. J. Virol. 78:5934-5945. (Pubitemid 38661681)
9. Cole, S. T., and O. Danos. 1987. Nucleotide sequence and comparative analysis of the human papillomavirus type 18 genome. Phylogeny of papillomaviruses and repeated structure of the E6 and E7 gene products. J. Mol. Biol. 193:599-608.
10. D'Souza, G., A. R. Kreimer, R. Viscidi, M. Pawlita, C. Fakhry, W. M. Koch, W. H. Westra, and M. L. Gillison. 2007. Case-control study of human papillomavirus and oropharyngeal cancer. N. Engl. J. Med. 356:1944-1956.
11. Duensing, S., A. Duensing, E. R. Flores, A. Do, P. F. Lambert, and K. Munger. 2001. Centrosome abnormalities and genomic instability by episomal expression of human papillomavirus type 16 in raft cultures of human keratinocytes. J. Virol. 75:7712-7716. (Pubitemid 32738029)
12. Duensing, S., L. Y. Lee, A. Duensing, J. Basile, S. Piboonniyom, S. Gonzalez, C. P. Crum, and K. Munger. 2000. The human papillomavirus type 16 E6 and E7 oncoproteins cooperate to induce mitotic defects and genomic instability by uncoupling centrosome duplication from the cell division cycle. Proc. Natl. Acad. Sci. USA 97:10002-10007.
13. Duensing, S., and K. Munger. 2002. Human papillomaviruses and centrosome duplication errors: modeling the origins of genomic instability. Oncogene 21:6241-6248.
14. Dürst, M., R. T. Dzarlieva Petrusevska, P. Boukamp, N. E. Fusenig, and L. Gissmann. 1987. Molecular and cytogenetic analysis of immortalized human primary keratinocytes obtained after transfection with human papillomavirus type 16 DNA. Oncogene 1:251-256. (Pubitemid 17149184)
15. Dürst, M., S. Seagon, S. Wanschura, H. zur Hausen, and J. Bullerdiek. 1995. Malignant progression of an HPV16-immortalized human keratinocyte cell line (HPKIA) in vitro. Cancer Genet. Cytogenet. 85:105-112.
16. Frattini, M. G., H. B. Lim, J. Doorbar, and L. A. Laimins. 1997. Induction of human papillomavirus type 18 late gene expression and genomic ampli- fication in organotypic cultures from transfected DNA templates. J. Virol. 71:7068-7072.
17. Frattini, M. G., H. B. Lim, and L. A. Laimins. 1996. In vitro synthesis of oncogenic human papillomaviruses requires episomal genomes for differentiation- dependent late expression. Proc. Natl. Acad. Sci. USA 93:3062-3067.
18. Gillison, M. L., W. M. Koch, R. B. Capone, M. Spafford, W. H. Westra, L. Wu, M. L. Zahurak, R. W. Daniel, M. Viglione, D. E. Symer, K. V. Shah, and D. Sidransky. 2000. Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. J. Natl. Cancer Inst. 92:709-720.
19. Gissmann, L., M. Boshart, M. Dürst, H. Ikenberg, D. Wagner, and H. zur Hausen. 1984. Presence of human papillomavirus in genital tumors. J. Investig. Dermatol. 83:26s-28s.
20. Gissmann, L., V. Diehl, H. J. Schultz Coulon, and H. zur Hausen. 1982. Molecular cloning and characterization of human papilloma virus DNA derived from a laryngeal papilloma. J. Virol. 44:393-400.
21. Hafner, N., C. Driesch, M. Gajda, L. Jansen, R. Kirchmayr, I. B. Runnebaum, and M. Durst. 2008. Integration of the HPV16 genome does not invariably result in high levels of viral oncogene transcripts. Oncogene 27: 1610-1617. (Pubitemid 351347875)
22. Haugen, T. H., M. J. Lace, T. Ishiji, A. Sameshima, J. R. Anson, and L. P. Turek. 2009. Cellular factors are required to activate bovine papillomavirus- 1 early gene transcription and to establish viral plasmid persistence but are not required for cellular transformation. Virology 389:82-90.
23. Hebner, C. M., and L. A. Laimins. 2006. Human papillomaviruses: basic mechanisms of pathogenesis and oncogenicity. Rev. Med. Virol. 16:83-97.
24. Helt, A. M., J. O. Funk, and D. A. Galloway. 2002. Inactivation of both the retinoblastoma tumor suppressor and p21 by the human papillomavirus type 16 E7 oncoprotein is necessary to inhibit cell cycle arrest in human epithelial cells. J. Virol. 76:10559-10568.
25. Hooley, E., V. Fairweather, A. R. Clarke, K. Gaston, and R. L. Brady. 2006. The recognition of local DNA conformation by the human papillomavirus type 6 E2 protein. Nucleic Acids Res. 34:3897-3908. (Pubitemid 44391005)
26. Hubert, W. G. 2005. Variant upstream regulatory region sequences differentially regulate human papillomavirus type 16 DNA replication throughout the viral life cycle. J. Virol. 79:5914-5922.
27. Hubert, W. G., T. Kanaya, and L. A. Laimins. 1999. DNA replication of human papillomavirus type 31 is modulated by elements of the upstream regulatory region that lie 5′ of the minimal origin. J. Virol. 73:1835-1845.
28. Ishiji, T., M. J. Lace, S. Parkkinen, R. D. Anderson, T. H. Haugen, T. P. Cripe, J. H. Xiao, I. Davidson, P. Chambon, and L. P. Turek. 1992. Transcriptional enhancer factor (TEF)-1 and its cell-specific co-activator activate human papillomavirus-16 E6 and E7 oncogene transcription in human keratinocytes and cervical carcinoma cells. EMBO J. 11:2271-2281.
29. James, M. A., J. H. Lee, and A. J. Klingelhutz. 2006. Human papillomavirus type 16 E6 activates NF-κB, induces cIAP-2 expression, and protects against apoptosis in a PDZ binding motif-dependent manner. J. Virol. 80:5301-5307.
30. Jeon, S., B. L. Allen-Hoffmann, and P. F. Lambert. 1995. Integration of human papillomavirus type 16 into the human genome correlates with a selective growth advantage of cells. J. Virol. 69:2989-2997.
31. Jewers, R. J., P. Hildebrandt, J. W. Ludlow, B. Kell, and D. J. McCance. 1992. Regions of human papillomavirus type 16 E7 oncoprotein required for immortalization of human keratinocytes. J. Virol. 66:1329-1335.
32. Kaur, P., and J. K. McDougall. 1989. HPV-18 immortalization of human keratinocytes. Virology 173:302-310.
33. Klussmann, J. P., S. J. Weissenborn, U. Wieland, V. Dries, H. E. Eckel, H. J. Pfister, and P. G. Fuchs. 2003. Human papillomavirus-positive tonsillar carcinomas: a different tumor entity? Med. Microbiol. Immunol. (Berlin) 192:129-132.
34. Kurman, R. J., M. H. Schiffman, W. D. Lancaster, R. Reid, A. B. Jenson, G. F. Temple, and A. T. Lörincz. 1988. Analysis of individual human papillomavirus types in cervical neoplasia: a possible role for type 18 in rapid progression. Am. J. Obstet. Gynecol. 159:293-296.
35. Lace, M. J., J. R. Anson, A. J. Klingelhutz, H. Harada, T. Taniguchi, A. D. Bossler, T. H. Haugen, and L. P. Turek. 2009. Interferon-beta treatment increases human papillomavirus early gene transcription and viral plasmid genome replication by activating interferon regulatory factor (IRF)-1. Carcinogenesis 30:1336-1344.
36. Lace, M. J., J. R. Anson, G. S. Thomas, L. P. Turek, and T. H. Haugen. 2008. The E8-E2 gene product of human papillomavirus type 16 represses early transcription and replication but is dispensable for viral plasmid persistence in keratinocytes. J. Virol. 82:10841-10853.
37. Lace, M. J., J. R. Anson, L. P. Turek, and T. H. Haugen. 2008. Functional mapping of the human papillomavirus type 16 E1 cistron. J. Virol. 82:10724-10734. (Pubitemid 352691198)
38. Lace, M. J., C. Isacson, J. R. Anson, A. T. Lorincz, S. P. Wilczynski, T. H. Haugen, and L. P. Turek. 2009. Upstream regulatory region alterations found in human papillomavirus type 16 (HPV-16) isolates from cervical carcinomas increase transcription, ori function, and HPV immortalization capacity in culture. J. Virol. 83:7457-7466.
39. Lee, J. H., S. M. Yi, M. E. Anderson, K. L. Berger, M. J. Welsh, A. J. Klingelhutz, and M. A. Ozbun. 2004. Propagation of infectious human papillomavirus type 16 by using an adenovirus and Cre/LoxP mechanism. Proc. Natl. Acad. Sci. USA 101:2094-2099.
40. Lörincz, A. T., A. P. Quinn, M. D. Goldsborough, B. J. Schmidt, and G. F. Temple. 1989. Cloning and partial DNA sequencing of two new human papillomavirus types associated with condylomas and low-grade cervical neoplasia. J. Virol. 63:2829-2834.
41. Mantovani, F., and L. Banks. 2001. The human papillomavirus E6 protein and its contribution to malignant progression. Oncogene 20:7874-7887. (Pubitemid 33135314)
42. Massimi, P., N. Gammoh, M. Thomas, and L. Banks. 2004. HPV E6 specifically targets different cellular pools of its PDZ domain-containing tumour suppressor substrates for proteasome-mediated degradation. Oncogene 23: 8033-8039. (Pubitemid 39531844)
43. McCance, D. J., R. Kopan, E. Fuchs, and L. A. Laimins. 1988. Human papillomavirus type 16 alters human epithelial cell differentiation in vitro. Proc. Natl. Acad. Sci. USA 85:7169-7173.
44. McMurray, H. R., and D. J. McCance. 2004. Degradation of p53, not telomerase activation, by E6 is required for bypass of crisis and immortalization by human papillomavirus type 16 E6/E7. J. Virol. 78:5698-5706.
45. Menges, C. W., L. A. Baglia, R. Lapoint, and D. J. McCance. 2006. Human papillomavirus type 16 E7 up-regulates AKT activity through the retinoblastoma protein. Cancer Res. 66:5555-5559.
46. Meyers, C., M. G. Frattini, J. B. Hudson, and L. A. Laimins. 1992. Biosynthesis of human papillomavirus from a continuous cell line upon epithelial differentiation. Science 257:971-973.
47. Meyers, C., T. J. Mayer, and M. A. Ozbun. 1997. Synthesis of infectious human papillomavirus type 18 in differentiating epithelium transfected with viral DNA. J. Virol. 71:7381-7386. (Pubitemid 27391677)
48. Ong, C. K., S. Y. Chan, M. S. Campo, K. Fujinaga, P. Mavromara-Nazos, V. Labropoulou, H. Pfister, S. K. Tay, J. ter Meulen, L. L. Villa, and H. U. Bernard. 1993. Evolution of human papillomavirus type 18: An ancient phylogenetic root in Africa and intratype diversity reflect coevolution with human ethnic groups. J. Virol. 67:6424-6431.
49. Park, R. B., and E. J. Androphy. 2002. Genetic analysis of high-risk e6 in episomal maintenance of human papillomavirus genomes in primary human keratinocytes. J. Virol. 76:11359-11364.
50. Patel, D., A. Incassati, N. Wang, and D. J. McCance. 2004. Human papillomavirus type 16 E6 and E7 cause polyploidy in human keratinocytes and up-regulation of G2-M-phase proteins. Cancer Res. 64:1299-1306. (Pubitemid 38235597)
51. Patterson, N. A., J. L. Smith, and M. A. Ozbun. 2005. Human papillomavirus type 31b infection of human keratinocytes does not require heparan sulfate. J. Virol. 79:6838-6847.
52. Pei, X. F., N. G. Qin, J. M. Meck, and R. Schlegel. 1994. Keratinocytes immortalized by human papillomavirus-18 exhibit alterations dependent upon host genetic background and complexity of viral genes transfected. Pathobiology 62:43-52.
53. Pirisi, L., S. Yasumoto, M. Feller, J. Doniger, and J. A. DiPaolo. 1987. Transformation of human fibroblasts and keratinocytes with human papillomavirus type 16 DNA. J. Virol. 61:1061-1066. (Pubitemid 17044016)
54. Pista, A., A. Oliveira, A. Barateiro, H. Costa, N. Verdasca, and M. T. Paixao. 2007. Molecular variants of human papillomavirus type 16 and 18 and risk for cervical neoplasia in Portugal. J. Med. Virol. 79:1889-1897.
55. Psyrri, A., and D. DiMaio. 2008. Human papillomavirus in cervical and head-and-neck cancer. Nat. Clin. Pract. Oncol. 5:24-31.
56. Rheinwald, J. G., and M. A. Beckett. 1981. Tumorigenic keratinocyte lines requiring anchorage and fibroblast support cultures from human squamous cell carcinomas. Cancer Res. 41:1657-1663.
57. Rheinwald, J. G., and H. Green. 1975. Serial cultivation of strains of human epidermal keratinocytes: the formation of keratinizing colonies from single cells. Cell 6:331-343.
58. Romanczuk, H., L. L. Villa, R. Schlegel, and P. M. Howley. 1991. The viral transcriptional regulatory region upstream of the E6 and E7 genes is a major determinant of the differential immortalization activities of human papillomavirus types 16 and 18. J. Virol. 65:2739-2744.
59. Schwarz, E., U. K. Freese, L. Gissmann, W. Mayer, B. Roggenbuck, A. Stremlau, and H. zur Hausen. 1985. Structure and transcription of human papillomavirus sequences in cervical carcinoma cells. Nature 314:111-114.
60. Shamanin, V. A., and E. J. Androphy. 2004. Immortalization of human mammary epithelial cells is associated with inactivation of the p14ARF-p53 pathway. Mol. Cell. Biol. 24:2144-2152.
61. Smith, E. M., J. M. Ritchie, K. F. Summersgill, H. T. Hoffman, D. H. Wang, T. H. Haugen, and L. P. Turek. 2004. Human papillomavirus in oral exfoliated cells and risk of head and neck cancer. J. Natl. Cancer Inst. 96:449-455.
62. Solinas-Toldo, S., M. Dürst, and P. Lichter. 1997. Specific chromosomal imbalances in human papillomavirus-transfected cells during progression toward immortality. Proc. Natl. Acad. Sci. USA 94:3854-3859.
63. Sprague, D. L., S. L. Phillips, C. J. Mitchell, K. L. Berger, M. Lace, L. P. Turek, and A. J. Klingelhutz. 2002. Telomerase activation in cervical keratinocytes containing stably replicating human papillomavirus type 16 episomes. Virology 301:247-254.
64. Stanley, M. A., H. M. Browne, M. Appleby, and A. C. Minson. 1989. Properties of a non-tumorigenic human cervical keratinocyte cell line. Int. J. Cancer 43:672-676.
65. Thomas, J. T., S. T. Oh, S. S. Terhune, and L. A. Laimins. 2001. Cellular changes induced by low-risk human papillomavirus type 11 in keratinocytes that stably maintain viral episomes. J. Virol. 75:7564-7571.
66. Ushikai, M., M. J. Lace, Y. Yamakawa, M. Kono, J. Anson, T. Ishiji, S. Parkkinen, N. Wicker, M. E. Valentine, I. Davidson, L. P. Turek, and T. H. Haugen. 1994. trans activation by the full-length E2 proteins of human papillomavirus type 16 and bovine papillomavirus type 1 in vitro and in vivo: cooperation with activation domains of cellular transcription factors. J. Virol. 68:6655-6666.
67. Veeraraghavalu, K., M. Pett, R. V. Kumar, P. Nair, A. Rangarajan, M. A. Stanley, and S. Krishna. 2004. Papillomavirus-mediated neoplastic progression is associated with reciprocal changes in JAGGED1 and manic fringe expression linked to notch activation. J. Virol. 78:8687-8700. (Pubitemid 39025134)
68. Walker, J., J. D. Bloss, S. Y. Liao, M. Berman, S. Bergen, and S. P. Wilczynski. 1989. Human papillomavirus genotype as a prognostic indicator in carcinoma of the uterine cervix. Obstet. Gynecol. 74:781-785.
69. Wilson, V. G., M. West, K. Woytek, and D. Rangasamy. 2002. Papillomavirus E1 proteins: form, function, and features. Virus Genes 24:275-290. (Pubitemid 34615304)
70. Wise-Draper, T. M., and S. I. Wells. 2008. Papillomavirus E6 and E7 proteins and their cellular targets. Front. Biosci. 13:1003-1017.
71. Woodworth, C. D., J. Doniger, and J. A. DiPaolo. 1989. Immortalization of human foreskin keratinocytes by various human papillomavirus DNAs corresponds to their association with cervical carcinoma. J. Virol. 63:159-164.
72. Xi, L. F., L. A. Koutsky, A. Hildesheim, D. A. Galloway, C. M. Wheeler, R. L. Winer, J. Ho, and N. B. Kiviat. 2007. Risk for high-grade cervical intraepithelial neoplasia associated with variants of human papillomavirus types 16 and 18. Cancer Epidemiol. Biomarkers Prev. 16:4-10.